Agreed. From a logical stand point this is the best move they...

First 120 Last

Share
Profile

Follow
BeanPile

152 Posts.

3

07/09/18

16:08

Post #: 35468761
Share

Originally posted by Maysgr ↑

Time will tell.

You may not be able to object (if it comes that) if the form does not arrive in time.

I see the chances of shareholders objecting as quite low at this stage.

Taurus would be crazy to make us a new offer that would even make us think twice about objecting.

Not doing that is only going to cost them time and money as they will be forced to go to court as well as pay court costs.

They should be factoring in any possible court costs when they revise their offer.

If they were smart they would be in contact with 3rd largest shareholder, and ensuring he was on side with what they propose the new offer will be.

He owns around 30% of the remaining non-T2 shares and would have the power to send this to court on his own.
He has plenty of coal industry experience and I am sure is no push over.

They know they are getting it cheap, just pay up and be done with it.

There are only about 9 million shares they don't own.

Trying to be stingy and smart can only backfire on them.

The only thing they have control over is the price we are offered. There is no point tempting fate and leaving it to the court, or backing out of a 100% ownership attempt now.

If it's high enough, then end of story.

Expand

Agreed. From a logical stand point this is the best move they can make now.

They've already made their win on shaking everyone out for the last 2 years. To play more games now for the remaining amounts of change only has the potential to do them more harm.

RRP Price at posting: 8.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga